由CCT3和CCT7角域抑制tau聚合
Miki Ben-Maimon1, Nadav Elad2, Segev Naveh-Tassa1
1Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.
概括
人类的CCT3和CCT7蛋白域抑制陶聚合,这是阿尔茨海默氏症和帕金森病的关键因素. 它们独特的机制为神经退行性疾病提供了新的治疗点.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 含有t复合多1 (CCT/TRiC) 的真核伴蛋白是一种重要的分子伴蛋白,参与蛋白质折叠.
- CCT/TRiC包括两个堆叠的环,每个环有八个独特的子单元.
- 陶聚合与神经退行性疾病 (如阿尔茨海默氏症和帕金森症) 有关.
研究的目的:
- 为了研究人类CCT3和CCT7基域对tau聚合的抑制作用.
- 阐明CCT3和CCT7子单元抑制tau聚合的独特机制.
主要方法:
- 进行了动力学分析,以研究tau聚合.
- 负染色电子显微镜可视化了tau与CCT领域的相互作用.
- 粗粒度分子动力学模拟模型模拟了结合相互作用.
主要成果:
- 人类CCT3和CCT7的顶端域显著抑制tau聚合.
- 在存在CCT7 (碎片化模型) 和CCT3 (和延伸和碎片化) 的情况下,tau聚合动力学有所不同.
- 分子动力学模拟揭示了tau与CCT3和CCT7.7的顶端域之间明显的结合相互作用.
结论:
- 人类CCT3和CCT7顶域是tau聚合的强有力的抑制剂.
- 独特的抑制机制表明,在神经退行性疾病中,CCT3和CCT7具有特殊的治疗潜力.
- 了解这些相互作用,可以了解陪伴者功能和疾病病理学.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Microtubule Associated Proteins (MAPs)
4.1K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.1K


